Colorectal News and Research

RSS

AVEO third quarter net loss increases to $23.8 million

AVEO Pharmaceuticals, Inc. today reported consolidated financial results for the third quarter of 2011 and provided an update on the tivozanib clinical program.

2 Nov 2011

First study to assess improvements in colorectal cancer detection through physician training

The first study to assess improvements in detection of pre-cancerous growths in the colon through intensive physician training was presented at the American College of Gastroenterology's 76th Annual Scientific Meeting, where colorectal cancer detection was an important focus of the scientific presentations.

1 Nov 2011

'Mozart Effect' may increase detection rates of precancerous polyps

Physicians who listen to Mozart while performing colonoscopy may increase their detection rates of precancerous polyps, according to the results of a new study unveiled today at the American College of Gastroenterology's (ACG) 76th Annual Scientific meeting in Washington, DC.

1 Nov 2011

Aspirin may reduce risk of bowel cancer by half: Study

According to a new study published in The Lancet, a regular dose of aspirin may not only stave off heart disease but also cut the risk of developing hereditary cancer in half.

31 Oct 2011

Cigarette smokers at risk of compromised digestive function

Cigarette smoking appears to impair pancreatic duct cell function--even for those who quit--putting all smokers at risk of compromised digestive function regardless of age, gender and alcohol intake, according to the results of a study unveiled today at the American College of Gastroenterology's (ACG) 76th Annual Scientific meeting in Washington, DC.

31 Oct 2011

Focused training increases physician's ability to find potentially precancerous polyps

Just two extra hours of focused training significantly increased the ability of physicians to find potentially precancerous polyps, known as adenomas, in the colon, according to researchers at Mayo Clinic in Florida. These findings suggest that new methods to educate endoscopists, the physicians who examine the colon, could increase colorectal cancer detection rates and potentially reduce cancer deaths.

31 Oct 2011

Vegenics receives IND approval from FDA for VGX-100 Phase I study in late stage cancers

Circadian Technologies Limited announces that its 100% owned subsidiary, Vegenics Pty Ltd, has received approval for its investigational new drug application from the U.S. Food and Drug Administration to initiate clinical trials of VGX-100.

31 Oct 2011

GC-C agonists have potential to delay progression of colitis into colon cancer

Synergy Pharmaceuticals, Inc., a developer of new drugs to treat gastrointestinal (GI) disorders and diseases, today announced that poster P409 presented at the upcoming 2011 annual scientific meeting of the American College of Gastroenterology highlights the potential use of guanylate cyclase-C agonists to delay progression of colitis into colon cancer.

31 Oct 2011

Pacira's third quarter total revenues decrease to $4.0 million

Pacira Pharmaceuticals, Inc., an emerging specialty pharmaceutical company, today announced financial results for the third quarter ended September 30, 2011 and provided an update on the U.S. Food and Drug Administration's (FDA) approval of EXPAREL and the commercial strategy to support the product launch.

31 Oct 2011

Research roundup: Medicaid's long-term care bill; work-based coverage and the health law

This study examined Medicare data on beneficiaries diagnosed with colorectal cancer between 1995 and 2005 who ranged from 67 to 85 years old. The authors found, "Medicare beneficiaries with colon cancer had better outcomes if they had more primary care utilization before diagnosis. Even within this universally insured population, 28% of Medicare beneficiaries with colon cancer had no or only 1 contact with primary care physicians in the 3 to 27 months before the diagnosis.

29 Oct 2011

Two new studies could provide tools to prevent rehospitalizations after major surgeries

Studies have shown that patients returning to the hospital soon after they've been discharged may cost Medicare up to billions of dollars each year, but two new studies presented at the 2011 Annual Clinical Congress of the American College of Surgeons could give surgical teams and their patients tools to prevent rehospitalizations.

28 Oct 2011

Annual chest radiographic screening does not reduce lung cancer mortality

In a trial that included more than 150,000 participants, those who underwent annual chest radiographic screening for up to 4 years did not have a significantly lower rate of death from lung cancer compared to participants who were not screened, according to a study in the November 2 issue of JAMA.

27 Oct 2011

Simple walking test can predict how well seniors would recover from operations

An elderly person's walking speed can predict how well he or she will fare after an operation, according to new findings presented at the 2011 Annual Clinical Congress of the American College of Surgeons. Researchers from the University of Colorado, Denver, reported that a simple, walking test that typically takes less than 20 seconds was a powerful tool for predicting how well seniors would recover from various surgical procedures.

27 Oct 2011

Bayer's regorafenib Phase 3 trial on metastatic colorectal cancer meets primary endpoint

Onyx Pharmaceuticals, Inc. today announced results from a Bayer HealthCare Pharmaceuticals Phase 3 trial evaluating the investigational compound regorafenib (BAY 73-4506) for the treatment of patients with metastatic colorectal cancer (mCRC) whose disease has progressed after approved standard therapies.

27 Oct 2011

Chest X ray for lung cancer fails to improve survival compared to no screening: Study

This study followed 154,901 participants, about half of whom were women. About 10 percent were current smokers, and the rest were nearly evenly divided between former smokers and people who never smoked. Subjects were either offered a chest X-ray or no screening at all.

27 Oct 2011

Six prominent surgeons receive ACS' Honorary Fellowship

Honorary Fellowship in the American College of Surgeons (ACS) was awarded to six prominent surgeons from South Africa, England, Ireland, Italy, The Netherlands, and the People's Republic of China last night during Convocation ceremonies that preceded the official opening of the College's 97th Annual Clinical Congress.

24 Oct 2011

NSAID may lower risk of death from colorectal cancer among postmenopausal women

Postmenopausal women who reported having used nonsteroidal anti-inflammatory drugs for at least 10 years at the time of enrollment in the Women's Health Initiative study had a lower risk for death from colorectal cancer compared with women who reported no use of these drugs at enrollment, according to data presented at the 10th AACR International Conference on Frontiers in Cancer Prevention Research, held Oct. 22-25, 2011.

24 Oct 2011

Light to moderate alcohol intake does not appear to increase risk of all-site cancer

A paper from the National Institutes of Health in the United States has evaluated the separate and combined effects of the frequency of alcohol consumption and the average quantity of alcohol drunk per occasion and how that relates to mortality risk from individual cancers as well as all cancers.

21 Oct 2011

Fecal immunochemical testing an inexpensive alternative to colonoscopy

Eventually, colon cancers bleed and so tests for blood in stool seem an inexpensive and noninvasive alternative to traditional colonoscopies. In fact, a recent article in the journal Cancer Prevention Research showed that fecal immunochemical testing (FIT) is an accurate predictor of colorectal cancer and can provide a low-cost screening alternative for medically underserved populations.

21 Oct 2011

TGen collaborates with Samuel Oschin Comprehensive Cancer Institute for clinical trials

Cedars-Sinai has combined efforts with the Translational Genomics Research Institute (TGen) in Arizona so researchers may offer joint clinical trials and collaborate to develop personalized therapies that could lead to more effective cancer treatments.

20 Oct 2011

Colorectal News and Research

AVEO third quarter net loss increases to $23.8 million

First study to assess improvements in colorectal cancer detection through physician training

'Mozart Effect' may increase detection rates of precancerous polyps

Aspirin may reduce risk of bowel cancer by half: Study

Cigarette smokers at risk of compromised digestive function

Focused training increases physician's ability to find potentially precancerous polyps

Vegenics receives IND approval from FDA for VGX-100 Phase I study in late stage cancers

GC-C agonists have potential to delay progression of colitis into colon cancer

Pacira's third quarter total revenues decrease to $4.0 million

Research roundup: Medicaid's long-term care bill; work-based coverage and the health law

Two new studies could provide tools to prevent rehospitalizations after major surgeries

Annual chest radiographic screening does not reduce lung cancer mortality

Simple walking test can predict how well seniors would recover from operations

Bayer's regorafenib Phase 3 trial on metastatic colorectal cancer meets primary endpoint

Chest X ray for lung cancer fails to improve survival compared to no screening: Study

Six prominent surgeons receive ACS' Honorary Fellowship

NSAID may lower risk of death from colorectal cancer among postmenopausal women

Light to moderate alcohol intake does not appear to increase risk of all-site cancer

Fecal immunochemical testing an inexpensive alternative to colonoscopy

TGen collaborates with Samuel Oschin Comprehensive Cancer Institute for clinical trials

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest News